120 related articles for article (PubMed ID: 1689662)
1. Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation.
Funderud S; Erikstein B; Asheim HC; Nustad K; Stokke T; Blomhoff HK; Holte H; Smeland EB
Eur J Immunol; 1990 Jan; 20(1):201-6. PubMed ID: 1689662
[TBL] [Abstract][Full Text] [Related]
2. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
[TBL] [Abstract][Full Text] [Related]
3. Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS).
Semple JW; Allen D; Chang W; Castaldi P; Freedman J
Cytometry; 1993 Nov; 14(8):955-60. PubMed ID: 7507026
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
5. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
6. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
7. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
[TBL] [Abstract][Full Text] [Related]
9. Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms.
Smith SH; Rigley KP; Callard RE
Immunology; 1991 Jul; 73(3):293-7. PubMed ID: 1715315
[TBL] [Abstract][Full Text] [Related]
10. Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters.
Meyer TP; Zehnter I; Hofmann B; Zaisserer J; Burkhart J; Rapp S; Weinauer F; Schmitz J; Illert WE
J Immunol Methods; 2005 Dec; 307(1-2):150-66. PubMed ID: 16325197
[TBL] [Abstract][Full Text] [Related]
11. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
12. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
Waddick KG; Uckun FM
Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
[TBL] [Abstract][Full Text] [Related]
13. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
Hamano T; Asofsky R
J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
[TBL] [Abstract][Full Text] [Related]
14. Modulation of expression of the antigen identified by FMC7 upon human B-lymphocyte activation: evidence for differences between activation in vivo and in vitro.
Ferro LM; Zola H
Immunology; 1990 Mar; 69(3):373-8. PubMed ID: 2138127
[TBL] [Abstract][Full Text] [Related]
15. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors.
Wolf ML; Weng WK; Stieglbauer KT; Shah N; LeBien TW
J Immunol; 1993 Jul; 151(1):138-48. PubMed ID: 7686930
[TBL] [Abstract][Full Text] [Related]
16. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
Golay J; Cusmano G; Introna M
J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
[TBL] [Abstract][Full Text] [Related]
17. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
Hamano T; Leiserson WM; Asofsky R
J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
[TBL] [Abstract][Full Text] [Related]
18. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
Chaouchi N; Vazquez A; Galanaud P; Leprince C
J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
[TBL] [Abstract][Full Text] [Related]
19. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
20. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
